{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:05:30Z","timestamp":1792800330545,"version":"4.5.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515110034"],"award-info":[{"award-number":["2023A1515110034"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005892","name":"China Academy of Chinese Medical Sciences","doi-asserted-by":"publisher","award":["CI2021B014"],"award-info":[{"award-number":["CI2021B014"]}],"id":[{"id":"10.13039\/501100005892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005892","name":"China Academy of Chinese Medical Sciences","doi-asserted-by":"publisher","award":["CI2023D003"],"award-info":[{"award-number":["CI2023D003"]}],"id":[{"id":"10.13039\/501100005892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005892","name":"China Academy of Chinese Medical Sciences","doi-asserted-by":"publisher","award":["CI2023D008"],"award-info":[{"award-number":["CI2023D008"]}],"id":[{"id":"10.13039\/501100005892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005892","name":"China Academy of Chinese Medical Sciences","doi-asserted-by":"publisher","award":["CI2023E002"],"award-info":[{"award-number":["CI2023E002"]}],"id":[{"id":"10.13039\/501100005892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005892","name":"China Academy of Chinese Medical Sciences","doi-asserted-by":"publisher","award":["CI2021A05101"],"award-info":[{"award-number":["CI2021A05101"]}],"id":[{"id":"10.13039\/501100005892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005892","name":"China Academy of Chinese Medical Sciences","doi-asserted-by":"publisher","award":["CI2021A05104"],"award-info":[{"award-number":["CI2021A05104"]}],"id":[{"id":"10.13039\/501100005892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20200109120205924"],"award-info":[{"award-number":["JCYJ20200109120205924"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["RCBS20210706092213007"],"award-info":[{"award-number":["RCBS20210706092213007"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M712189"],"award-info":[{"award-number":["2022M712189"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFE0204500"],"award-info":[{"award-number":["2023YFE0204500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2303600"],"award-info":[{"award-number":["2022YFC2303600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017380","name":"Science and Technology Foundation of Shenzhen City","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017380","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017127","name":"Shenzhen Government","doi-asserted-by":"publisher","award":["KCXFZ20201221173612034"],"award-info":[{"award-number":["KCXFZ20201221173612034"]}],"id":[{"id":"10.13039\/100017127","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373775"],"award-info":[{"award-number":["82373775"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U24A20798"],"award-info":[{"award-number":["U24A20798"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404492"],"award-info":[{"award-number":["82404492"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.xcrm.2025.102191","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T11:04:53Z","timestamp":1750158293000},"page":"102191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Probiotic-mediated tumor microenvironment reprogramming with protease-sensitive interleukin-15 and photothermal therapy"],"prefix":"10.1016","volume":"6","author":[{"given":"Huifang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuhai","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanbin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runhua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongda","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangwei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinpeng","family":"Cen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2025.102191_bib1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41568-023-00560-y","article-title":"Dynamics and specificities of T cells in cancer immunotherapy","volume":"23","author":"Oliveira","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2025.102191_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41573-022-00557-6","article-title":"Emerging principles of cytokine pharmacology and therapeutics","volume":"22","author":"Saxton","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2025.102191_bib3","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/s41551-022-00888-0","article-title":"Masking the immunotoxicity of interleukin-12 by fusing it with a domain of its receptor via a tumour-protease-cleavable linker","volume":"6","author":"Mansurov","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.xcrm.2025.102191_bib4","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nri1901","article-title":"The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design","volume":"6","author":"Waldmann","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2025.102191_bib5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1073\/pnas.1814642116","article-title":"IL-15 is a component of the inflammatory milieu in the tumor microenvironment promoting antitumor responses","volume":"116","author":"Santana Carrero","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102191_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007240","article-title":"Functional network pipeline reveals genetic determinants associated with in situ lymphocyte proliferation and survival of cancer patients","volume":"6","author":"Mlecnik","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2025.102191_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001428","article-title":"Interleukin-15 and cancer: some solved and many unsolved questions","volume":"8","author":"Fiore","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.xcrm.2025.102191_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131242","article-title":"Favorable alteration of tumor microenvironment by immunomodulatory cytokines for efficient T-cell therapy in solid tumors","volume":"10","author":"Tahtinen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2025.102191_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s40425-019-0623-z","article-title":"Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III-IV melanoma","volume":"7","author":"Andtbacka","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.xcrm.2025.102191_bib10","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1182\/blood-2011-12-400044","article-title":"Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning","volume":"119","author":"Pegram","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.102191_bib11","article-title":"Interleukin 15 in Cell-Based Cancer Immunotherapy","volume":"23","author":"Zhou","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2025.102191_bib12","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa1910607","article-title":"Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors","volume":"382","author":"Liu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102191_bib13","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s12015-020-10092-9","article-title":"Treatment of Aggressive T Cell Lymphoblastic Lymphoma\/leukemia Using Anti-CD5 CAR T Cells","volume":"17","author":"Feng","year":"2021","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.xcrm.2025.102191_bib14","doi-asserted-by":"crossref","first-page":"4940","DOI":"10.1158\/0008-5472.CAN-07-0283","article-title":"The antibody-mediated targeted delivery of interleukin-15 and GM-CSF to the tumor neovasculature inhibits tumor growth and metastasis","volume":"67","author":"Kaspar","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102191_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006221","article-title":"Antibody-based delivery of interleukin-2 to neovasculature has potent activity against acute myeloid leukemia","volume":"5","author":"Gutbrodt","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2025.102191_bib16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jconrel.2015.05.282","article-title":"Vascular-targeted TNFalpha improves tumor blood vessel function and enhances antitumor immunity and chemotherapy in colorectal cancer","volume":"210","author":"Lu","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.xcrm.2025.102191_bib17","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/ni.3836","article-title":"De novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors","volume":"18","author":"Johansson-Percival","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2025.102191_bib18","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.4161\/mabs.28699","article-title":"Highly potent anti-CD20-RLI immunocytokine targeting established human B lymphoma in SCID mouse","volume":"6","author":"Vincent","year":"2014","journal-title":"mAbs"},{"key":"10.1016\/j.xcrm.2025.102191_bib19","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41551-020-0549-2","article-title":"Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours","volume":"4","author":"Mansurov","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.xcrm.2025.102191_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau3259","article-title":"Targeted antibody and cytokine cancer immunotherapies through collagen affinity","volume":"11","author":"Ishihara","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2025.102191_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0297-0","article-title":"Bacteria-cancer interactions: bacteria-based cancer therapy","volume":"51","author":"Duong","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.xcrm.2025.102191_bib22","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1126\/science.add9667","article-title":"Engineering bacteria as interactive cancer therapies","volume":"378","author":"Gurbatri","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102191_bib23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nature18930","article-title":"Synchronized cycles of bacterial lysis for in vivo delivery","volume":"536","author":"Din","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102191_bib24","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/s41587-022-01244-y","article-title":"A programmable encapsulation system improves delivery of therapeutic bacteria in mice","volume":"40","author":"Harimoto","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102191_bib25","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1158\/1078-0432.CCR-17-2451","article-title":"A First-in-Human Phase I Study of Subcutaneous Outpatient Recombinant Human IL15 (rhIL15) in Adults with Advanced Solid Tumors","volume":"24","author":"Miller","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102191_bib26","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.1158\/1078-0432.CCR-18-3468","article-title":"IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion","volume":"25","author":"Conlon","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102191_bib27","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3389\/fimmu.2020.00868","article-title":"IL-15 in the Combination Immunotherapy of Cancer","volume":"11","author":"Waldmann","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2025.102191_bib28","doi-asserted-by":"crossref","first-page":"E10915","DOI":"10.1073\/pnas.1811615115","article-title":"IL-15 enhanced antibody-dependent cellular cytotoxicity mediated by NK cells and macrophages","volume":"115","author":"Zhang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102191_bib29","doi-asserted-by":"crossref","first-page":"7513","DOI":"10.1073\/pnas.0902637106","article-title":"Interleukin-15 combined with an anti-CD40 antibody provides enhanced therapeutic efficacy for murine models of colon cancer","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102191_bib30","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.1073\/pnas.1203479109","article-title":"Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model","volume":"109","author":"Yu","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102191_bib31","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1158\/2326-6066.CIR-19-0338","article-title":"Radiotherapy Cooperates with IL15 to Induce Antitumor Immune Responses","volume":"8","author":"Pilones","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.xcrm.2025.102191_bib32","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41573-024-00920-9","article-title":"Targeting immunogenic cell stress and death for cancer therapy","volume":"23","author":"Galluzzi","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2025.102191_bib33","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41590-022-01132-2","article-title":"Immunogenic cell stress and death","volume":"23","author":"Kroemer","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2025.102191_bib34","doi-asserted-by":"crossref","first-page":"12938","DOI":"10.1093\/nar\/gkac1164","article-title":"Targeted bacterial conjugation mediated by synthetic cell-to-cell adhesions","volume":"50","author":"Robledo","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2025.102191_bib35","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.4049\/jimmunol.1500300","article-title":"IL-15 Superagonist-Mediated Immunotoxicity: Role of NK Cells and IFN-gamma","volume":"195","author":"Guo","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2025.102191_bib36","doi-asserted-by":"crossref","first-page":"6748","DOI":"10.1038\/s41467-023-42155-z","article-title":"Biomimetic nanovaccine-mediated multivalent IL-15 self-transpresentation (MIST) for potent and safe cancer immunotherapy","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102191_bib37","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1073\/pnas.0610115104","article-title":"The IL-15\/IL-15Ralpha on cell surfaces enables sustained IL-15 activity and contributes to the long survival of CD8 memory T cells","volume":"104","author":"Sato","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102191_bib38","doi-asserted-by":"crossref","first-page":"16428","DOI":"10.1021\/jacs.1c05090","article-title":"PhotothermalPhage: A Virus-Based Photothermal Therapeutic Agent","volume":"143","author":"Shahrivarkevishahi","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.xcrm.2025.102191_bib39","doi-asserted-by":"crossref","first-page":"4468","DOI":"10.1038\/s41467-022-31932-x","article-title":"Spatiotemporal control of engineered bacteria to express interferon-gamma by focused ultrasound for tumor immunotherapy","volume":"13","author":"Chen","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102191_bib40","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1021\/acsnano.8b02235","article-title":"Bacteria-Driven Hypoxia Targeting for Combined Biotherapy and Photothermal Therapy","volume":"12","author":"Chen","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.xcrm.2025.102191_bib41","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.1038\/s41467-019-12771-9","article-title":"Mild photothermal therapy potentiates anti-PD-L1 treatment for immunologically cold tumors via an all-in-one and all-in-control strategy","volume":"10","author":"Huang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102191_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201700805","article-title":"Fever-Inspired Immunotherapy Based on Photothermal CpG Nanotherapeutics: The Critical Role of Mild Heat in Regulating Tumor Microenvironment","volume":"5","author":"Li","year":"2018","journal-title":"Adv. Sci."},{"key":"10.1016\/j.xcrm.2025.102191_bib43","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1126\/science.add7034","article-title":"Probiotic-guided CAR-T cells for solid tumor targeting","volume":"382","author":"Vincent","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102191_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.807271","article-title":"Targeting Tryptophan Catabolism in Cancer Immunotherapy Era: Challenges and Perspectives","volume":"13","author":"Peyraud","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2025.102191_bib45","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000599","article-title":"Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-gamma, CXCL9 and CXCL10","volume":"8","author":"Bergamaschi","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.xcrm.2025.102191_bib46","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm1523","article-title":"Calreticulin exposure dictates the immunogenicity of cancer cell death","volume":"13","author":"Obeid","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.102191_bib47","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1046\/j.1365-2249.2001.01672.x","article-title":"IL-15-induced conversion of monocytes to mature dendritic cells","volume":"126","author":"Saikh","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.xcrm.2025.102191_bib48","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/eji.200636329","article-title":"IL-15-induced human DC efficiently prime melanoma-specific naive CD8+ T cells to differentiate into CTL","volume":"37","author":"Dubsky","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.xcrm.2025.102191_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1184703","article-title":"Research progress of interleukin-15 in cancer immunotherapy","volume":"14","author":"Cai","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.xcrm.2025.102191_bib50","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2209021119","article-title":"Responsiveness to interleukin-15 therapy is shared between tissue-resident and circulating memory CD8(+) T cell subsets","volume":"119","author":"Jarjour","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102191_bib51","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.molimm.2019.11.011","article-title":"Control of memory CD8(+) T cell longevity and effector functions by IL-15","volume":"117","author":"Nolz","year":"2020","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.xcrm.2025.102191_bib52","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1084\/jem.20100643","article-title":"Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity","volume":"207","author":"Sakuishi","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.xcrm.2025.102191_bib53","article-title":"Characterization of neoantigen-specific T cells in cancer resistant to immune checkpoint therapies","volume":"118","author":"Li","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102191_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110129","article-title":"5-FU mediated depletion of myeloid suppressor cells enhances T-cell infiltration and anti-tumor response in immunotherapy-resistant lung tumor","volume":"120","author":"Mathew","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.xcrm.2025.102191_bib55","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1002\/cam4.2474","article-title":"Are 90% of deaths from cancer caused by metastases?","volume":"8","author":"Dillekas","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.xcrm.2025.102191_bib56","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41586-021-04003-2","article-title":"Metabolic modulation of tumours with engineered bacteria for immunotherapy","volume":"598","author":"Canale","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102191_bib57","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aak9537","article-title":"Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin","volume":"9","author":"Zheng","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2025.102191_bib58","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1038\/s41467-021-26367-9","article-title":"Intracellular delivery of protein drugs with an autonomously lysing bacterial system reduces tumor growth and metastases","volume":"12","author":"Raman","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102191_bib59","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adc9436","article-title":"Chemokines expressed by engineered bacteria recruit and orchestrate antitumor immunity","volume":"9","author":"Savage","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2025.102191_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122135","article-title":"Synergistic cancer immunotherapy utilizing programmed Salmonella typhimurium secreting heterologous flagellin B conjugated to interleukin-15 proteins","volume":"298","author":"Zhang","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.xcrm.2025.102191_bib61","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1038\/s41467-023-39224-8","article-title":"Bioengineering of bacteria for cancer immunotherapy","volume":"14","author":"Nguyen","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102191_bib62","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijmm.2007.01.008","article-title":"Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live mice","volume":"297","author":"Stritzker","year":"2007","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.xcrm.2025.102191_bib63","doi-asserted-by":"crossref","DOI":"10.1093\/femsle\/fnw212","article-title":"Escherichia coli strain Nissle 1917-from bench to bedside and back: history of a special Escherichia coli strain with probiotic properties","volume":"363","author":"Sonnenborn","year":"2016","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.xcrm.2025.102191_bib64","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nbt.4222","article-title":"Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria","volume":"36","author":"Isabella","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102191_bib65","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax0876","article-title":"Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies","volume":"12","author":"Gurbatri","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2025.102191_bib66","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.tips.2022.02.002","article-title":"Emerging strategies for engineering Escherichia coli Nissle 1917-based therapeutics","volume":"43","author":"Lynch","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.xcrm.2025.102191_bib67","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1158\/1078-0432.CCR-23-0118","article-title":"Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies","volume":"29","author":"Luke","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102191_bib68","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/s41591-019-0498-z","article-title":"Programmable bacteria induce durable tumor regression and systemic antitumor immunity","volume":"25","author":"Chowdhury","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.102191_bib69","article-title":"Near-Infrared Nano-Optogenetic Activation of Cancer Immunotherapy via Engineered Bacteria","volume":"35","author":"Zhu","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.xcrm.2025.102191_bib70","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s43018-023-00536-9","article-title":"Precision-activated T-cell engagers targeting HER2 or EGFR and CD3 mitigate on-target, off-tumor toxicity for immunotherapy in solid tumors","volume":"4","author":"Cattaruzza","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.xcrm.2025.102191_bib71","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/s41422-021-00543-4","article-title":"Tumor-conditional IL-15 pro-cytokine reactivates anti-tumor immunity with limited toxicity","volume":"31","author":"Guo","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.xcrm.2025.102191_bib72","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1158\/1078-0432.CCR-19-1457","article-title":"Probody Therapeutics: An Emerging Class of Therapies Designed to Enhance On-Target Effects with Reduced Off-Tumor Toxicity for Use in Immuno-Oncology","volume":"26","author":"Autio","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102191_bib73","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41392-021-00833-8","article-title":"From prodrug to pro-prodrug: hypoxia-sensitive antibody-drug conjugates","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.xcrm.2025.102191_bib74","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1186\/s12885-021-08974-3","article-title":"Tumor-immune profiling of CT-26 and Colon 26 syngeneic mouse models reveals mechanism of anti-PD-1 response","volume":"21","author":"Sato","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.xcrm.2025.102191_bib75","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001691","article-title":"Differential combination immunotherapy requirements for inflamed (warm) tumors versus T cell excluded (cool) tumors: engage, expand, enable, and evolve","volume":"9","author":"Fabian","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.xcrm.2025.102191_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217272","article-title":"Cellular dynamics of tumor microenvironment driving immunotherapy resistance in non-small-cell lung carcinoma","volume":"604","author":"Huang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.xcrm.2025.102191_bib77","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41571-023-00789-4","article-title":"Antigen presentation in cancer - mechanisms and clinical implications for immunotherapy","volume":"20","author":"Yang","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2025.102191_bib78","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.xcrm.2025.102191_bib79","doi-asserted-by":"crossref","first-page":"18590","DOI":"10.1073\/pnas.1906929116","article-title":"Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study","volume":"116","author":"Rastinehad","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102191_bib80","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1841393","article-title":"Regulatory approval of photoimmunotherapy: photodynamic therapy that induces immunogenic cell death","volume":"9","author":"Gomes-da-Silva","year":"2020","journal-title":"OncoImmunology"},{"key":"10.1016\/j.xcrm.2025.102191_bib81","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1158\/0008-5472.CAN-12-1003","article-title":"Effective photothermal chemotherapy using doxorubicin-loaded gold nanospheres that target EphB4 receptors in tumors","volume":"72","author":"You","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102191_bib82","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41571-020-0410-2","article-title":"Clinical development and potential of photothermal and photodynamic therapies for cancer","volume":"17","author":"Li","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2025.102191_bib83","first-page":"122","article-title":"The non-pathogenic Escherichia coli strain Nissle 1917\u2013features of a versatile probiotic","volume":"21","author":"Sonnenborn","year":"2009","journal-title":"Microb. Ecol. Health Dis."},{"key":"10.1016\/j.xcrm.2025.102191_bib84","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/1753425910396251","article-title":"Anti-inflammatory modulation of immune response by probiotic Escherichia coli Nissle 1917 in human blood mononuclear cells","volume":"18","author":"Guttsches","year":"2012","journal-title":"Innate Immun."},{"key":"10.1016\/j.xcrm.2025.102191_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121458","article-title":"Nanoprodrug ratiometrically integrating autophagy inhibitor and genotoxic agent for treatment of triple-negative breast cancer","volume":"283","author":"Wang","year":"2022","journal-title":"Biomaterials"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125002642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125002642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:18:44Z","timestamp":1778919524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379125002642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":85,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2666379125002642"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102191","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Probiotic-mediated tumor microenvironment reprogramming with protease-sensitive interleukin-15 and photothermal therapy","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102191","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102191"}}